Approval · Notice of Compliance 685 · 2002
TESLASCAN: Notice of Compliance 685
Issued May 15, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 685
- Date
- May 15, 2002
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TESLASCAN | 02241555 | Cancelled Post Market |
Medicinal ingredients
- MANGAFODIPIR TRISODIUM 37.9 MG per ML